People: Cellavision AB (CLVSF.PK)
CLVSF.PK on OTC Markets Group - US Other OTC and Grey Market
2.27USD
27 Jun 2012
2.27USD
27 Jun 2012
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$2.27
$2.27
Open
--
--
Day's High
$2.27
$2.27
Day's Low
$2.27
$2.27
Volume
500
500
Avg. Vol
0
0
52-wk High
$2.50
$2.50
52-wk Low
$2.09
$2.09
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Lars Gatenbeck |
57 | 2010 | Independent Chairman of the Board |
Yvonne Martensson |
60 | 1998 | President, Chief Executive Officer |
Sven-Ake Henningsson |
73 | 2012 | Acting Chief Financial Officer, Independent Director |
Stefan Bengtsson |
55 | 2011 | Chief Operating Officer |
Ron Hagner |
59 | 2012 | Vice President of Sales & Business Development |
Peter Wilson |
46 | Marketing & Customer Support Manager | |
Hans Bengtsson |
55 | Quality Assurance Manager | |
Christer Fahraeus |
48 | 1998 | Director |
Lars Henriksson |
52 | 2011 | Director |
Roger Johanson |
54 | 2011 | Independent Director |
Torbjorn Kronander |
56 | 2007 | Independent Director |
Anna Malm Bernsten |
52 | 2010 | Independent Director |
Biographies
| Name | Description |
|---|---|
Lars Gatenbeck |
Dr. Lars Gatenbeck has served as Independent Chairman of the Board of Directors of CellaVision AB since December 2010. He was Chairman of the Board of Directors of the Company between 2002 and December 2010. He serves as Chairman of the Company's Remuneration Committee and Member of the Company's Audit Committee. He has been Member of the Board of Directors of the Company since 2000. He is Chairman of the Board of Life Equity Group Holding AB, Swecare AB, Stiftelsen Swecare and Life Medical Sweden AB. He is President and Chairman of the Board of H&B Capital Advisors AB, H&B Sweden AB and Life Equity Advisors AB. He is Member of the Boards of Aleris Holding AB, Cancerforeningen and Stiftelsen Silviahemmet and Principal in Gustav V:s Jubileumsfond. In the past, he served as Director of Karolinska University Hospital. He holds a Doctorate of Medicine and a Doctorate in Philosophy. |
Yvonne Martensson |
Ms. Yvonne Martensson has served as President and Chief Executive Officer of CellaVision AB. She has been employed in the Company since 1998. She is Member of the Board of Aerocrine AB, Biolin Scientific Holding AB and Lunds universitets innovationssystem AB. She has more than 25 years experience of international marketing and sales in fast-growing companies in various phases, and more than 20 years experiences from the medtech industry. She holds a Master of Science Degree in Industrial Engineering and Management. |
Sven-Ake Henningsson |
Mr. Sven-Ake Henningsson has been appointed Acting Chief Financial Officer of CellaVision AB as of September 1, 2012 and has served as Independent Member of the Board of Directors of the Company since 2006. He was Chairman of the Audit Committee. He is Chairman of the Board of ACAP invest AB and Rittal Scandinavian AB. He is Member of the Board of Gant Company AB, Gant Home AB and DIAB International AB. He holds a Bachelor of Science Degree in Economics and Business Administration. |
Stefan Bengtsson |
Mr. Stefan Bengtsson has been Chief Operating Officer of CellaVision AB since 2011. He has over 20 years of experience from medical device companies. His most recent position was Chief Executive Officer of Presona AB, a supplier of compacting equipment in the recycling industry. He held managerial positions in Gambro, Getinge and Pharmacia. Mr. Bengtsson holds a Master of Science Degree in Mechanical Engineering. |
Ron Hagner |
Mr. Ron Hagner has served as Vice President of Sales & Business Development at CellaVision AB since April 27, 2012. He joined the Company in 2001 and was responsible for, among others, establishing CellaVision's sales offices in the United States and Canada. Mr. Hagner holds a Master of Science degree in Medical Biology. |
Peter Wilson |
Mr. Peter Wilson serves as Marketing & Customer Support Manager at CellaVision AB. He has been employed by the Company since 2000. He has many years of experience from global launching of new technologies and new products. He previously worked for Foss, among others. He holds a Master of Science Degree in Chemical Engineering. |
Hans Bengtsson |
Mr. Hans-Inge Bengtsson serves as Quality Assurance (QA) Manager at CellaVision AB. He has been employed by the Company since 2001. He has experience of regulatory work, within R&D, clinical laboratory and pharma. His former positions include PolyPeptide Laboratories AB and Hemocue. He holds a Master of Science degree in Chemical Engineering. |
Christer Fahraeus |
Mr. Christer Fahraeus has been Member of the Board of Directors of CellaVision AB since 1994. He was also Chief Executive Officer of the Company until June, 1998. He is founder of the Company. He serves as Member of the Company's Remuneration Committee. His former positions include Chief Executive Officer of Anoto Group AB and Agellis Group AB. He is founder of Anoto Group AB, Precise Biometrics AB and Agellis Group AB among others. He is Chief Executive Officer of EQL Pharma AB. He is Chairman of the Board of Agellis Group AB, Respiratorius AB and Flatfrog Laboratories AB. He is Member of the Board of EQL Pharma AB, Lunds universitets innovationssystem AB, Monkfish Instruments AB, Faro Capital AB and Karo Bio AB. He holds a Master of Science Degree in Bioengineering and a Bachelor of Science Degree in Mathematics from Lunds Universitet. He also holds a honoris causa Doctorate in Philosophy from Lunds Universitet. |
Lars Henriksson |
Mr. Lars Henriksson has served as Member of the Board of Directors of CellaVision AB since 2011. He has been Chairman of the Company's Audit Committee as of July 4, 2012. He serves as Investment Manager and Business Analyst at Industrifonden in the Life Science business area. His former positions include Chief Financial Officer in telecoms and traditional industry on an international basis. Mr. Henriksson serves as alternate in several cases under mandate from Industrifonden and is Member of the Board of directors of Diashunt Intressenter AB. He holds Master of Science Degree in Industrial Engineering and Management. |
Roger Johanson |
Mr. Roger Johanson has served as Independent Member of the Board of Directors of CellaVision AB since 2011. He serves as Head of Venture Capital & Direct Investments at Skandia Liv. His former positions include Chief Executive Officer and President at Medicarb AB and management positions at Boehringer Mannheim Scandinavica AB, DAKO A/S and Becton Dickinson AB. He holds a Master of Science Degree in Chemical Engineering. |
Torbjorn Kronander |
Mr. Torbjorn Kronander has served as Independent Member of the Board of Directors of CellaVision AB since 2007. He is Member of the Company's Remuneration Committee. He is Chairman of the Board of Sectra Sverige AB and Sectra Mamea AB. He is President of Sectra Imtec AB and Vice President of Sectra AB, as well as founder of Sectras’ medical division and co-founder of the research center, CMIV (Center for Medical Image Science and Visualization) in Linkoping, where he also serves as Member of the Board of Directors. He is also Member of the Board of Milly Medical AB, Ancylus OU and Shannon AB. He holds a Doctorate of Technology and a Masters of Business Administration Degree. |
Anna Malm Bernsten |
Ms. Anna Malm Bernsten has served as Independent Member of the Board of Directors of CellaVision AB since April 29, 2010. She has been Member of the Company's Audit Committee as of July 4, 2012. She is Chief Executive Officer of Bernsten Konsult AB. She is Member of the Board of AB Fagerhult, Medivir AB, Artimplant AB, Nolato AB, Birdstep ASA and Matrisen AB. Her former positions include Chief Executive Officer and President of Carmeda AB and management positions at Pharmacia & Upjohn and GE Healthcare Life Sciences. She holds a Master of Science Degree in Chemical Engineering. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Lars Gatenbeck |
300,000 |
Yvonne Martensson |
2,569,000 |
Sven-Ake Henningsson |
120,000 |
Stefan Bengtsson |
-- |
Ron Hagner |
-- |
Peter Wilson |
-- |
Hans Bengtsson |
-- |
Christer Fahraeus |
120,000 |
Lars Henriksson |
120,000 |
Roger Johanson |
100,000 |
Torbjorn Kronander |
120,000 |
Anna Malm Bernsten |
100,000 |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Lars Gatenbeck |
0 | 0 |
Yvonne Martensson |
0 | 0 |
Sven-Ake Henningsson |
0 | 0 |
Stefan Bengtsson |
0 | 0 |
Ron Hagner |
0 | 0 |
Peter Wilson |
0 | 0 |
Hans Bengtsson |
0 | 0 |
Christer Fahraeus |
0 | 0 |
Lars Henriksson |
0 | 0 |
Roger Johanson |
0 | 0 |
Torbjorn Kronander |
0 | 0 |
Anna Malm Bernsten |
0 | 0 |

